Bora Pharmaceuticals, a full-service contract development and manufacturing organization (CDMO) which specializes in immediate and modified release tablets and capsules, along with serialized packaging, has appointed four business development directors to its commercial teams in the U.S. and Taiwan.   The appointments aim to support the company’s planned acquisition of GSK’s facility in Mississauga, Canada.   Firstly, Mark Dawson joins the team as senior director of business development. Based o...